Sars Cov 2 Spike Protein - Infectious Diseases

Relevant Publications

COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.

Issue Release: 2024

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.

Issue Release: 2024

PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2.

Issue Release: 2024

Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236.

Issue Release: 2024

Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris.

Issue Release: 2024

Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model.

Issue Release: 2024

On-mask detection of SARS-CoV-2 related substances by surface enhanced Raman scattering.

Issue Release: 2024

The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2.

Issue Release: 2024

Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics.

Issue Release: 2024

Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice.

Issue Release: 2024

Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study.

Issue Release: 2024

Molecular interactions of the Omicron, Kappa, and Delta SARS-CoV-2 spike proteins with quantum dots of graphene oxide.

Issue Release: 2024

Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.

Issue Release: 2024

Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model.

Issue Release: 2024

Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.

Issue Release: 2024

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug.

Issue Release: 2024

SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic.

Issue Release: 2024

Spike deep mutational scanning helps predict success of SARS-CoV-2 clades.

Issue Release: 2024

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.

Issue Release: 2024

A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV.

Issue Release: 2024

Which Diseases Have Been Eradicated?

What Are the Limitations of Inherited Immunity?

What are Adenoviruses?

How Does Climate Change Influence Infectious Diseases?

Are There Any Side Effects of Folate Biosynthesis Inhibitors?

How Does Co-Infection Occur?

When are Imaging Studies Recommended?

What are the risks associated with Dengvaxia?

Are There Any Recent Developments in Yellow Fever Research?

Can Vaccinations Help Prevent Infectious Diseases in Pregnancy?

Partnered Content Networks

Relevant Topics